News
IVAX obtained an exclusive option to license CBR's technology," said Edmundo Stahl, M.D., director of pulmonary clinical research for IVAX.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback